OBJECTIVES Decellularized aortic homografts (DAH) were introduced in 2008 as a further
option for paediatric aortic valve replacement (AVR). METHODS Prospective, multicentre …

OBJECTIVES Options for paediatric aortic valve replacement (AVR) are limited if valve
repair is not feasible. Results of paediatric Ross procedures are inferior to adult Ross …

The treatment of aortic valve disease in paediatric patients yields various options, from
catheter-based valvuloplasty or surgical valve repair to valve replacement. Despite …

OBJECTIVES The choice of valve prosthesis for aortic valve replacement (AVR) in young
patients is challenging. Decellularized pulmonary homografts (DPHs) have shown excellent …

OBJECTIVES Decellularized aortic homografts (DAH) may provide an additional aortic valve
replacement option for young patients due to their potential to overcome the high early …

Background: decellularized aortic homografts (DAH) represent a promising alternative for
aortic valve replacement in young adults due to their low immunogenicity and …

Background: this study was performed to assess the results of aortic valve replacement in
children with biological substitutes including homografts, pulmonary autografts (Ross …

The implantation of a decellularized aortic homograft in children and young adults has been
shown to be a good alternative to existing surgical approaches. Lower risk of calcification …

BACKGROUND: The availability of an ideal prosthesis for aortic valve replacement (AVR) in
children remains controversial due to an early degeneration of xenografts and the potential …

Objective The ideal valve substitute for surgical intervention of congenital aortic valve
disease in children remains unclear. Data on outcomes beyond 10–15 years after valve …